title: A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results.
authors.affiliation: Division of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico.
authors.forename: Jaime
authors.initials: J
authors.lastname: Coronel
authors.forename: Lucely
authors.initials: L
authors.lastname: Cetina
authors.forename: Irlanda
authors.initials: I
authors.lastname: Pacheco
authors.forename: Catalina
authors.initials: C
authors.lastname: Trejo-Becerril
authors.forename: Aurora
authors.initials: A
authors.lastname: González-Fierro
authors.forename: Erick
authors.initials: E
authors.lastname: de la Cruz-Hernandez
authors.forename: Enrique
authors.initials: E
authors.lastname: Perez-Cardenas
authors.forename: Lucia
authors.initials: L
authors.lastname: Taja-Chayeb
authors.forename: Daymi
authors.initials: D
authors.lastname: Arias-Bofill
authors.forename: Myrna
authors.initials: M
authors.lastname: Candelaria
authors.forename: Silvia
authors.initials: S
authors.lastname: Vidal
authors.forename: Alfonso
authors.initials: A
authors.lastname: Dueñas-González